4109
加捷生醫
+0.05 (+0.45%)11.10120成交張數368.33本益比0.81股價淨值比1.81%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入
營業收入2025485年增 -9.6%
毛利率202531.0%最新一期
營業利益率20250.1%最新一期
每股盈餘20250.43年增 -80.1%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業成本合計 | 64.4% | 74.7% | 72.7% | 74.4% | 84.6% | 65.5% | 63.3% | 64.6% | 67.7% | 69.0% | |
| 營業毛利（毛損） | 35.6% | 25.3% | 27.3% | 25.6% | 15.4% | 34.5% | 36.7% | 35.4% | 32.3% | 31.0% | |
| 營業毛利（毛損）淨額 | 35.6% | 25.3% | 27.3% | 25.6% | 15.4% | 34.5% | 36.7% | 35.4% | 32.3% | 31.0% | |
| 推銷費用 | 16.3% | 16.6% | 16.2% | 12.7% | 18.9% | 14.8% | 19.3% | 34.1% | 15.6% | 15.4% | |
| 管理費用 | 11.4% | 19.4% | 21.4% | 19.5% | 14.3% | 18.8% | 19.1% | 18.4% | 9.3% | 14.1% | |
| 研究發展費用 | 1.8% | 0.6% | 0.5% | 0.6% | 0.1% | 1.5% | 2.8% | 2.8% | 1.2% | 1.4% | |
| 預期信用減損損失（利益） | – | – | -0.3% | -1.1% | 0.0% | -0.1% | -0.2% | -0.1% | 0.0% | -0.0% | |
| 營業費用合計 | 29.6% | 36.6% | 37.8% | 31.7% | 33.3% | 34.9% | 41.0% | 55.2% | 26.1% | 30.8% | |
| 營業利益（損失） | 6.0% | -11.4% | -10.5% | -6.0% | -17.9% | -0.4% | -4.3% | -19.9% | 6.2% | 0.1% | |
| 利息收入 | – | – | – | – | 0.0% | 0.2% | 0.4% | 0.5% | 0.4% | 1.0% | |
| 其他收入 | 1.4% | 1.0% | 3.3% | 1.0% | 2.7% | 2.9% | 2.4% | 3.2% | 1.4% | 2.9% | |
| 其他利益及損失淨額 | 2.5% | -18.0% | 10.2% | -1.5% | 0.0% | -0.5% | 0.0% | 60.2% | 34.1% | 8.3% | |
| 財務成本淨額 | 1.3% | 1.8% | 2.3% | 0.8% | 0.3% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | |
| 營業外收入及支出合計 | -0.7% | -35.0% | 11.2% | -1.4% | 2.5% | 2.6% | 2.8% | 63.9% | 35.8% | 12.2% | |
| 稅前淨利（淨損） | 5.4% | -46.4% | 0.7% | -7.4% | -15.4% | 2.2% | -1.5% | 44.0% | 42.0% | 12.3% | |
| 所得稅費用（利益）合計 | 2.5% | 0.5% | 0.6% | -0.3% | -3.3% | 0.1% | 0.6% | -0.1% | 1.7% | 1.6% | |
| 繼續營業單位本期淨利（淨損） | 2.9% | -46.9% | 0.1% | -7.1% | -12.1% | 2.1% | -2.0% | 44.2% | 40.2% | 10.7% | |
| 本期淨利（淨損） | 2.9% | -46.9% | 0.1% | -7.1% | -12.1% | 2.1% | -2.0% | 44.2% | 40.2% | 10.7% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | 3.1% | 4.1% | -9.6% | -2.6% | -1.8% | 1.3% | -1.7% | 0.3% | |
| 不重分類至損益之項目： | – | – | – | 4.1% | -9.6% | -2.6% | -1.8% | 1.3% | -1.7% | 0.3% | |
| 國外營運機構財務報表換算之兌換差額 | -3.7% | -1.6% | -0.5% | -0.8% | -0.1% | -0.1% | 0.4% | -0.2% | 0.1% | -0.0% | |
| 後續可能重分類至損益之項目： | – | – | – | -0.8% | -0.1% | -0.1% | 0.4% | -0.2% | 0.1% | -0.0% | |
| 其他綜合損益（淨額） | -2.9% | -1.6% | 2.7% | 3.3% | -9.7% | -2.8% | -1.4% | 1.1% | -1.6% | 0.3% | |
| 本期綜合損益總額 | -0.0% | -48.5% | 2.8% | -3.8% | -21.8% | -0.7% | -3.4% | 45.3% | 38.7% | 11.1% | |
| 母公司業主（淨利∕損） | 1.9% | -44.5% | 0.6% | -7.1% | -11.8% | 2.2% | -1.7% | 43.3% | 39.4% | 10.4% | |
| 非控制權益（淨利∕損） | 1.0% | -2.4% | -0.5% | 0.0% | -0.3% | -0.1% | -0.3% | 0.9% | 0.9% | 0.4% | |
| 母公司業主（綜合損益） | -0.4% | -45.8% | 3.5% | -3.6% | -21.5% | -0.6% | -3.1% | 44.4% | 37.8% | 10.6% | |
| 非控制權益（綜合損益） | 0.4% | -2.7% | -0.8% | -0.2% | -0.3% | -0.1% | -0.3% | 1.0% | 0.9% | 0.4% | |
| 基本每股盈餘 | 0.0% | -0.5% | 0.0% | -0.1% | -0.2% | 0.0% | -0.0% | 0.5% | 0.4% | 0.1% | |
| 繼續營業單位淨利（淨損） | 0.0% | -0.0% | 0.0% | -0.0% | -0.0% | 0.0% | -0.0% | 0.0% | 0.0% | 0.0% | |
| 稀釋每股盈餘 | 0.0% | -0.5% | 0.0% | -0.1% | -0.2% | 0.0% | -0.0% | 0.5% | 0.4% | 0.1% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | -3.2% | -16.2% | 0.0% | – | – | – | – | 0.1% | 0.0% | – | |
| 與可能重分類之項目相關之所得稅 | -0.5% | 0.0% | -0.1% | 0.0% | – | – | – | – | – | – | |
| 備供出售金融資產未實現評價損益 | 0.3% | 0.0% | – | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。